JP2023509004A5 - - Google Patents
Info
- Publication number
- JP2023509004A5 JP2023509004A5 JP2022539412A JP2022539412A JP2023509004A5 JP 2023509004 A5 JP2023509004 A5 JP 2023509004A5 JP 2022539412 A JP2022539412 A JP 2022539412A JP 2022539412 A JP2022539412 A JP 2022539412A JP 2023509004 A5 JP2023509004 A5 JP 2023509004A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- polypeptide
- complex
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025284931A JP2026065032A (ja) | 2019-12-26 | 2025-12-26 | ニドゲンをベースとする足場タンパク質および治療用ナノ複合体 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19383201.1A EP3842452A1 (en) | 2019-12-26 | 2019-12-26 | Scaffold proteins and therapeutic nanoconjugates based on nidogen |
| PCT/EP2021/050409 WO2021130390A1 (en) | 2019-12-26 | 2021-01-11 | Scaffold proteins and therapeutic nanoconjugates based on nidogen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025284931A Division JP2026065032A (ja) | 2019-12-26 | 2025-12-26 | ニドゲンをベースとする足場タンパク質および治療用ナノ複合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509004A JP2023509004A (ja) | 2023-03-06 |
| JP2023509004A5 true JP2023509004A5 (https=) | 2024-01-17 |
| JP7810873B2 JP7810873B2 (ja) | 2026-02-04 |
Family
ID=69167593
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539412A Active JP7810873B2 (ja) | 2019-12-26 | 2021-01-11 | ニドゲンをベースとする足場タンパク質および治療用ナノ複合体 |
| JP2025284931A Pending JP2026065032A (ja) | 2019-12-26 | 2025-12-26 | ニドゲンをベースとする足場タンパク質および治療用ナノ複合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025284931A Pending JP2026065032A (ja) | 2019-12-26 | 2025-12-26 | ニドゲンをベースとする足場タンパク質および治療用ナノ複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230068834A1 (https=) |
| EP (2) | EP3842452A1 (https=) |
| JP (2) | JP7810873B2 (https=) |
| KR (1) | KR20220158680A (https=) |
| CN (1) | CN115210253A (https=) |
| AU (1) | AU2021204681A1 (https=) |
| BR (1) | BR112022012739A2 (https=) |
| CA (1) | CA3166013A1 (https=) |
| WO (1) | WO2021130390A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119264211A (zh) | 2018-08-27 | 2025-01-07 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| JP2023501385A (ja) * | 2019-11-08 | 2023-01-18 | ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 抗微生物ペプチドを含む組成物 |
| US12371463B2 (en) | 2021-04-20 | 2025-07-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods and compositions for treatment of antibiotic-resistant bacterial infections |
| WO2024235986A1 (en) * | 2023-05-15 | 2024-11-21 | Pharis Biotec Gmbh | Peptides for use in the treatment of sarcoma |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US5082927A (en) | 1986-09-24 | 1992-01-21 | The United States Of America As Represented By The Department Of Health And Human Services | Selectively cytotoxic IL-4-PE40 fusion protein |
| US5493008A (en) * | 1994-08-15 | 1996-02-20 | The University Of Virginia Patent Foundation | Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| US5622958A (en) | 1994-12-01 | 1997-04-22 | Sloan-Kettering Institute For Cancer Research | Enediyne quinone imines and methods of preparation and use thereof |
| GB2443370A (en) * | 2005-07-29 | 2008-04-30 | Australian Stem Cell Ct Ltd | Compositions and methods for growth of pluripotent cells |
| WO2007115376A1 (en) | 2006-04-11 | 2007-10-18 | The University Of Western Australia | Anti-angiogenic agents and methods of their use |
| US20110124564A1 (en) | 2009-08-25 | 2011-05-26 | Esperance Pharmaceuticals, Inc. | Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same |
| EP2476441A1 (en) * | 2011-01-13 | 2012-07-18 | Universitat Autònoma De Barcelona | Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| EP3427756A1 (en) | 2017-07-14 | 2019-01-16 | Universidad Autónoma De Barcelona (UAB) | Therapeutic nanoconjugates and uses thereof |
| AU2019265663B2 (en) * | 2018-05-08 | 2024-06-13 | Rutgers, The State University Of New Jersey | AAV-compatible laminin-linker polymerization proteins |
-
2019
- 2019-12-26 EP EP19383201.1A patent/EP3842452A1/en not_active Withdrawn
-
2021
- 2021-01-11 US US17/789,036 patent/US20230068834A1/en active Pending
- 2021-01-11 JP JP2022539412A patent/JP7810873B2/ja active Active
- 2021-01-11 CA CA3166013A patent/CA3166013A1/en active Pending
- 2021-01-11 WO PCT/EP2021/050409 patent/WO2021130390A1/en not_active Ceased
- 2021-01-11 BR BR112022012739A patent/BR112022012739A2/pt unknown
- 2021-01-11 CN CN202180017055.1A patent/CN115210253A/zh active Pending
- 2021-01-11 EP EP21701052.9A patent/EP4081538A1/en active Pending
- 2021-01-11 AU AU2021204681A patent/AU2021204681A1/en active Pending
- 2021-01-11 KR KR1020227026036A patent/KR20220158680A/ko active Pending
-
2025
- 2025-12-26 JP JP2025284931A patent/JP2026065032A/ja active Pending